Quang X Pham insider trades: Cadrenal Therapeutics (CVKD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Quang reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | CVKD | ↓ Sell10b5-1 | 7,400 | $3.03 | $22K | Direct | Jul 1, 2026 (2d) |
| Jun 26, 2026 | CVKD | ↓ Sell10b5-1 | 11,156 | $3.04 | $34K | Direct | Jun 26, 2026 (0d) |
| Jun 23, 2026 | CVKD | ↓ Sell10b5-1 | 11,444 | $3.48 | $40K | Direct | Jun 24, 2026 (1d) |
| Jun 17, 2026 | CVKD | ↓ Sell10b5-1 | 4,126 | $3.18 | $13K | Direct | Jun 18, 2026 (1d) |
| Jun 15, 2026 | CVKD | ↓ Sell10b5-1 | 18,124 | $3.88 | $70K | Direct | Jun 15, 2026 (0d) |
| Jun 10, 2026 | CVKD | ↓ Sell10b5-1 | 22,385 | $4.17 | $93K | Direct | Jun 10, 2026 (0d) |
| Jun 2, 2026 | CVKD | ↓ Sell10b5-1 | 652 | $4.72 | $3K | Direct | Jun 2, 2026 (0d) |
| May 28, 2026 | CVKD | ↓ Sell10b5-1 | 12,763 | $5.44 | $69K | Direct | May 29, 2026 (1d) |
| May 22, 2026 | CVKD | ↓ Sell10b5-1 | 1,165 | $5.69 | $7K | Direct | May 26, 2026 (4d) |
| Oct 27, 2025 | CVKD | ↓ Sell10b5-1 | 2,444 | $14.01 | $34K | Direct | Oct 28, 2025 (1d) |
| Oct 13, 2025 | CVKD | ↓ Sell10b5-1 | 3,600 | $14.09 | $51K | Direct | Oct 14, 2025 (1d) |
| Oct 2, 2025 | CVKD | ↓ Sell10b5-1 | 500 | $14.13 | $7K | Direct | Oct 3, 2025 (1d) |
| Oct 1, 2025 | CVKD | ↓ Sell10b5-1 | 1,300 | $14.01 | $18K | Direct | Oct 1, 2025 (0d) |
| Sep 25, 2025 | CVKD | ↓ Sell | 9,371 | $14.06 | $132K | Direct | Sep 26, 2025 (1d) |
| Aug 28, 2025 | CVKD | ↓ Sell | 5,029 | $13.99 | $70K | Direct | Aug 29, 2025 (1d) |
| Sep 5, 2023 | CVKD | ↑ Buy | 40,000 | $0.90 | $36K | Direct | Sep 6, 2023 (1d) |
| Sep 1, 2023 | CVKD | ↑ Buy | 70,000 | $0.91 | $64K | Direct | Sep 5, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CVKD insiders
Open-market trades in the last 12 months
About Quang X Pham's insider trades
Quang X Pham is Chairman and CEO at Cadrenal Therapeutics (CVKD). Since Sep 1, 2023, Quang has reported 2 open-market purchases worth $100K and 15 sales worth $664K on SEC Form 4. In the last 12 months: 9 sales ($352K).
13 sales (70% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (4 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVKD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.